Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma

Journal:
Journal of Clinical Investigation
Published:
DOI:
10.1172/jci200415
Affiliations:
3
Authors:
20
Go to article
Institutions Authors Share
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China
19.000000
19.000000
 0.95
MOE Key Laboratory of Gene Function and Regulation, SYSU, China
1.000000
 0.05
Interested in Oncology and Carcinogenesis?